The reactivity of squarylferrocenes was studied in the addition of several N-centered nucleophiles. A total of seven simple amines (primary and secondary) were added to both monosquarylferrocene and 1,1′-bissquarylferrocene to generate 14 ferrocenylsquaramides in 85-98%. Likewise, five aminoesters were added to the same scaffolds to produce a novel family of 10 ferrocene-aminoester conjugates in good to excellent yields (57-95%).
Introduction
After over fifty years of its discovery, ferrocene has become the starting material for the preparation of compounds with applications in different fields. 1 One emergent area in which ferrocene is playing already a leading role is bioorganometallic chemistry.
2 Some of the features that render ferrocene a very attractive candidate for applications in bioorganometallic chemistry include: its electroneutrality, chemical stability, redox properties, and non-toxicity. 3 As a result, a large number of reports have appeared in the literature dealing with the synthesis and biological activity of ferrocene bioconjugates. 4 One example that stands out with respect to its antiproliferative activity on mammary tumors is a family of ferrocene-containing Tamoxifen analogues called Ferrocifen (Figure 1 ). 5 Similarly, another class of important bioorganometallic compounds with significant medical applications is that of metal-peptide bioconjugates. Some of them have displayed interesting These derivatives are important because they incorporate a redox-active moiety which is, at the same time, a scaffold that may hold two peptide strands within H-bonding distance. Several research groups have disclosed the synthesis of ferrocene-peptides and described their use as: electrochemical biosensors, 7 redox-switching centers, etc.
8
A different organic fragment that has been attached to peptides is squaric acid or its derivatives. Squaric acid 1 is a very attractive molecule in its own right. It has been used in medicinal chemistry, 9 material science, 10 and organic synthesis.
11
Squaric acid-peptide hybrids have been incorporated to protein conjugates which mimic the polysaccharides found on the cell surfaces of different pathogens. 12 In another example, these compounds have been utilized as inhibitors of Matrix Metalloprotease 1. 13 Our group has disclosed the synthesis of squarylferrocenes 2 and 3 14 and shortly after that, building on our results, Zora et al. reported the synthesis of ferrocenylquinones from 2. We were pleased with the excellent reactivity displayed by both 2 and 3. The results are illustrated in Table 1 . a Isolated yield. For the series 11a-g, a 1:2 ratio of 2:amine was used. For the series 12a-g, a 1:4 ratio of 3:amine was used.
The addition of the amines 4-10 to 2 and 3 took place smoothly approaching quantitative yields in several cases. The i PrO-group in the squarylferrocenes showed excellent reactivity as leaving group in this addition-elimination process ( Figure 3 ). As expected on the basis of steric hindrance, primary amines reacted more rapidly than secondary ones. However, the yield did not decomposedrease. This trend was observed in both 11a-g and 12a-g series. Due to the fact that an excess of the amines were used in all cases, no evidence of the double addition product was observed in the case of piperazine in the 1 H NMR spectrum of the crude material (entries 3 and 10). No inert atmosphere was required and the reactions took place at room temperature. All of the products were deep red solids that could be purified by simply triturating the crude material with hexanes and ethyl ether.
Next, we turned our attention to the addition of aminoesters to squarylferrocenes 2 and 3. The aminoester hydrochlorides used are shown in Figure 4 . The results of this study are displayed in Table 2 . Commercially available aminoester hydrochlorides 13-17 were added to both 2 and 3. The reaction conditions were basically the same as those specified in Table 1 , except for the addition of a stoichiometric amount of Et3N to liberate the aminoester. The yields were somewhat lower than the case of the addition of simple amines, however, they ranged from acceptable to good. Except for the case of -alanine (entry 5), an increase in the reaction time was observed in all cases, especially in the addition of the aminoesters to the bis-squarylferrocene 3. This general observation may be attributed to the increased steric bulk at the position adjacent to the amino group in the aminoesters. As in the case of the addition of simple amines, products 18-19 were dark red solids that were purified by simple trituration of the crude material with hexanes and ethyl ether.
Ferrocenyl derivatives 18a-e and 19a-e, once hydrolyzed to the corresponding free carboxylic acids, may be used to incorporate other aminoacids or peptide chains.
Conclusions
Squarylferrocenes 2 and 3 exhibited excellent reactivity toward the addition of both primary and secondary amines. Likewise, aminoester conjugates were prepared in the same fashion in high yields. The possibility to react free amino oligopeptides directly to 2 and 3 in a convergent manner is being currently investigated in our group and will be disclosed in due course.
Experimental Section

General.
1 H NMR spectra were recorded on a Varian Gemini 200 (200 MHz) in DMSO-d6 (2.49 ppm) as internal reference unless otherwise indicated. Data are reported in the following order: chemical shift in ppm (δ), multiplicities (br (broadened)), s (singlet), d (doublet), t (triplet), q (quartet), sex (sextet), hep (heptet), m (multiplet), exch (exchangeable), app (apparent), coupling constants, J, are reported (Hz), and integration. Infrared spectra were recorded on a Perkin-Elmer FTRI 1600 series spectrophotometer. Peaks are reported (cm -1 ) with the following relative intensities: s (strong 67-100 %), m (medium 40-67 %), and w (weak 20-40%). Analytical thin-layer chromatography was performed on Merck silica gel plates with F-254 indicator. Accurate mass spectra were obtained on a Bruker microTOF fitted with an ESI.
General procedure for the synthesis of ferrocene monosquaramides (11a-g)
A 20-mL vial was charged with 2 (50 mg, 0.15 mmol, 1 equiv), the corresponding amine (0.30 mmol, 2 equiv), methanol (4 mL), and a magnetic stirrer. The vial was capped and the mixture was stirred until completion whereupon the solvent was removed under reduced pressure. The product was purified by simply trituration with hexanes and ethyl ether.
General procedure for the synthesis of ferrocene bissquaramides (12a-g)
A 20-mL vial was charged with 3 14b (50 mg, 0.11 mmol, 1 equiv), the corresponding amine (0.43 mmol, 4 equiv), methanol (4 mL), and a magnetic stirrer. The vial was capped and the mixture was stirred until completion whereupon the solvent was removed under reduced pressure. The product was purified by simply trituration with hexanes and ethyl ether. 1 H NMR (200 MHz, DMSO-d6): δ 4.7 (app t, J = 1.8 Hz, 2H), 4.6 (app t, J = 1.8, 2H), 3.9 (br, 2H), 3.8 (br, 2H), 1.6 (br, 6 H 1 H NMR (200 MHz, DMSOd6): δ 4.7 (br s, 2H), 4.6 (br s, 2H), 4.2 (s, 5H), 3.9 (br, 4H), 3.8 (br, 4H). 13 C NMR (50 MHz, 188.1, 175.7, 165.5, 71.0, 70.5, 69.7, 69.1, 65.6 Fe, 15.90; N, 3.99; O, 13.67. Found C, 61.66 ; H, 4.95; N, 3. 1 H NMR (200 MHz, DMSO-d6): δ 4.7 (br, 2H), 4.6 (br, 2H), 4.2 (s, 5 H), 3.8 (br, 4 H), 2.8 (br, 4H). 13 C NMR (50 MHz, 188.0, 175.4, 165.2, 70.9, 70.8, 69.7, 69.1, 49.6, 46.9, 45.4 1 H NMR (200 MHz, DMSO-d6): δ 9.0 (br, 1H), 7.6 (s, 1H), 6.4 (d, J = 9 Hz, 2H), 5.0 (s, 2H), 4.8 (app d, J = 3.2 Hz, 2H), 4.6 (s, 2H), 4.14 (s, 5H). 13 C NMR (50 MHz, DMSOd6): 191.6, 188.2, 177.8, 168.0, 151.3, 142.9, 110.6, 107.8, 71.4, 69.8, 67.5 188.0, 177.6, 167.8, 138.5, 128.6, 127.4, 127.3, 71.3, 69.9, 69.7, 67.4 13 C NMR (50 MHz, 188.1, 178.1, 167.0, 71.1, 70.2, 69.7, 67.3, 30.8. HRMS FABS (M+H) + Calcd for C15H14FeNO2: 296.0374. Found: 296.0365. Anal. Calcd for C15H13FeNO2: C, 61.05; H, 4.44; Fe, 18.92; N, 4.75; O, 10.84. Found C, 61.35; H, 4.29; N, 4. 192.5, 188.6, 177.3, 161.9, 76.0, 72.2, 70.7, 50.3, 48.3, 25.9, 25.3, 23.5 (br s, 2H). 13 C NMR (50 MHz, CDCl3): 192. 1, 188.7, 177.5, 162.3, 75.6, 72.6, 70.8, 66.7, 65.8 3-(piperazin-1yl)cyclobut-3-ene-1,2-dione) C NMR (50 MHz, 187.9, 177.2, 163.9, 150.9, 142.9, 110.6, 108.1, 72.6, 72.4, 68.7 13 C NMR (50 MHz, 187.9, 177.2, 163.7, 138.2, 128.6, 127.5, 72.9, 72.4, 68.6, 47.4 13 C NMR (50 MHz, 187.8, 177.1, 163.2, 134.8, 116.5, 72.9, 72.1, 68.42, 46.0 
4,4′-(1,1′-Ferrocenyl)bis(
4,4′-(1,1′-Ferrocenyl)bis(3-(furan-2-ylmethylamino)cyclobut-3-ene-1,2-dione) (12d)
.
. HRMS FABS (M+H)
+ Calcd for C24H21FeN2O4: 457.0851. Found: 457.0877. Anal. Calcd for C24H20FeN2O4: C, 63.18; H, 4.42; Fe, 12.24; N, 6.14; O, 14.03. Found C, 63.28; H, 4.22; N, 6.25 . -(1,1′-Ferrocenyl)bis(3-(methylamino)cyclobut-3-ene-1,2-dione) 3.99; Fe, 13.82; N, 6.93; O, 15.83. Found C, 59.08; H, 3.71, N, 6.82 .
General procedure for the synthesis of ferrocene monosquaramides (18a-e)
A 20-mL vial was charged with 2 (50 mg, 0.15 mmol, 1 equiv), the corresponding aminoester hydrochloride (0.30 mmol, 2 equiv), triethylamine (0.30 mmol, 2 equiv), methanol (4 mL), and a magnetic stirrer. The vial was capped and the mixture was stirred until completion whereupon the solvent was removed under reduced pressure. The product was purified by simply trituration with hexanes and ethyl ether.
General procedure for the synthesis of ferrocene bissquaramides (19a-e)
A 20-mL vial was charged with 3 (50 mg, 0.11 mmol, 1 equiv), the corresponding aminoester hydrochloride (0.43 mmol, 4 equiv), triethylamine (0.43 mmol, 4 equiv), methanol (4 mL), and a magnetic stirrer. The vial was capped and the mixture was stirred until completion whereupon the solvent was removed under reduced pressure. The product was purified by simply trituration with hexanes and ethyl ether. 192.3, 190.0, 179.5, 173.2, 169.9, 72.8, 71.1, 68.9, 68.8, 53.7, 53.4, 18.8. Anal. Calcd for C18H17FeNO4: C, 58.88; H, 4.67; N, 3.81. Found: C, 58.79; H, 4.56; N, 3.79 . 192.3, 179.5, 171.6, 170, 72.7, 71.1, 70.6, 69.0, 68.8, 63.4, 62.5, 32.5, 19.3, 18.4, 14.6. Anal. Calcd for C21H23FeNO4: C, 61.63; H, 5.66; N, 3.42. Found: C, 61.71; H, 5.54; N, 3.49 . 192.3, 189.9, 179.5, 173.1, 170.2, 72.8, 71.1, 70.5, 69.0, 68.7, 56.5, 53.3, 41.5, 25.6, 23.4, 21.3. Anal. Calcd for C21H23FeNO4: C, 61.63; H, 5.66; N, 3.42. Found: C, 61.52; H, 5.45; N, 3.71 . CD3CN ): δ 6.9 (d, J= 8.2 Hz, 1H), 4.9 (br s, 2 H), 4.6 (br s, 2 H), 4.2 (s, 5H), 4.2 (overlapped, 2H), 4.1 (q, J = 7 Hz, 2H), 2.56 (t, J=7.2 Hz, 2H), 2.3 ( t, J= 6.8 Hz, 1H), 2.1(app q, J= 6.4 Hz, 2H), 1.3 (m, J = 7 Hz, J = 6.6 Hz, 6H). 13 C NMR (50 MHz, CD3CN): δ 192.2, 190.0, 179.8, 173.7, 171.8, 170.2, 72.8, 71.1, 70.4, 68.9, 68.8, 62.8, 61.5, 57.4, 31.2, 28.0, 14.5. Anal. Calcd for C23H25FeNO6: C, 59.12; H, 5.39; N, 3.00; . Found: C, 59.02; H, 5.51; N, 3.28 . 1 H NMR (200 MHz, DMSO-d6): δ 8.5 ( br s, 1H), 5.0 (app t, J = 2 Hz, 2H), 4.6 (app t, J = 2 Hz, 2H) 4.1 (s, 5H), 4.1 (q, J = 7.2 Hz, 2H), 3.9 (q, J = 6.6 Hz, 2H), 2.7 (t, J = 6.4 Hz, 2H), 1.2 (t, J = 7 Hz, 3H). 13 C NMR (50 MHz, 188.0, 177.9, 170.6, 167.0, 71.2, 69.8, 69.6, 67.3, 60.0, 34.7, 15.1. Anal. Calcd for C19H19FeNO4: C, 59.86; H, 5.02; N, 3.67. Found: C, 59.67; H, 4.13; N, 3.79 . 2 Hz, 6H). 13 C NMR (50 MHz, DMSO-d6) :  192.3, 191.6, 191.0, 174.4, 172.1, 79.6, 74.2, 70.2, 69.5, 52.5, 22. CD3CN ): δ 6.9 (d, J = 9 Hz, 2H), 4.9 (app d, J = 5.2 Hz, 4H), 4.8 (dd, J = 6 Hz, J = 3.2 Hz, 2H), 4.6 (br s, 4 H), 4.3 (q, J = 6.6 Hz, 4H), 2.3 (m, 2H), 1.3 (t, J = 7 Hz, 6H), 1.1 (dd, J = 3.4 Hz, 12 H). 13 C NMR (50 MHz, DMSO-d6) :  191.7, 188.1, 178.1, 170.3, 165.5, 73.0, 71.6, 69.6, 69.1, 62.1, 61.0, 30.6, 18.7, 18.5, 14.0. Anal. Calcd for C32H36FeN2O8: C, 60.77; H, 5.74; N, 4.43. Found: C, 60.90; H, 5.68; N, 4.59 . 13 C NMR (50 MHz, CD3CN) : δ 192.48, 190, 180.12, 173.28, 167.49, 74.82, 74.61, 70.25, 69.8, 56.6, 53.3, 41.6, 25.5, 23.3, 21. 1.3 (m, 12H) . 13 C NMR (50 MHz, CD3CN) :  192.4, 189.9, 180.3, 173.9, 171.8, 74.7, 74.4, 72.7, 70.2, 69.7, 62.9, 61.5, 57.6, 31.2, 27.9, 14.5. Anal. Calcd for C36H40FeN2O12: C, 57.76; H, 5.39; N, 3.74. Found: C, 57.91; H, 5.12; N, 3.89 . 4H), 4.6 (s, 4H), 4.1 (q, J = 7 Hz, 4H), 3.8 (q, J = 6 Hz, 4H), 2.7 (t, J = 7 Hz, 4H), 1.2 (t, J = 7.2 Hz, 6H). 13 C NMR (50 MHz, DMSO-d6) :  191.8, 187.8, 177.2, 170.6, 162.5, 73.0, 72.2, 68.3, 60.1, 34.5, 13.9. Anal. Calcd for C28H28FeN2O8: C, 58.35; H, 4.90; N, 4.86. Found: C, 58.62; H, 4.98; N, 4.79. 
